Copaxone demonstrates remyelination & neuroprotective effect
Copaxone demonstrates remyelination & neuroprotective effect
Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with Copaxone(R) (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models. In the study, researchers compared mice treated with Copaxone(R) versus non-treated mice in relapsing-remitting and chronic multiple sclerosis (MS) disease models. Researchers observed both remyelination indicative of repair and a drastic reduction of demyelination and axonal loss in mice treated with Copaxone(R).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2002 Views
-
Last post by NHE
-
- 0 Replies
- 2206 Views
-
Last post by NHE
-
- 0 Replies
- 1336 Views
-
Last post by NHE
-
- 0 Replies
- 1231 Views
-
Last post by DIM
-
- 0 Replies
- 1034 Views
-
Last post by frodo
-
- 0 Replies
- 1112 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1085 Views
-
Last post by frodo
-
- 0 Replies
- 1254 Views
-
Last post by NHE
-
- 1 Replies
- 2882 Views
-
Last post by Tif